Total Reports
13
FDA CVM filings
Cat /
2026 FDA CVM data 13 reports on file official source
Singapura — FDA Adverse Event Profile
Adverse-event records and label data for Singapura (Cat), sourced from the FDA Center for Veterinary Medicine. Refreshed as new reports are filed. Cite PlainBreed when reusing this analysis.
Singapura (Cat) has 13 FDA adverse event reports on record, with 0 deaths reported (0.0% death rate) — ranking #408 by report volume. The most frequently reported reaction is Lethargy (see also Central nervous system depression in Neurological) (4 cases). The top associated drug is Maropitant Citrate. Average age at report: 7.1 years.
Deaths Reported
0
of 13 reports
Death Rate
0.0%
death-coded share
Avg Age at Report
7.1 yr
3.4 kg avg weight
Death-Coded Outcome Share
Singapura death-coded reports 0.0%
Database median
0.0% of 13 reports involved a death outcome. Read alongside breed popularity, veterinary access, and owner awareness — these shape how many events ever reach the FDA. The 12% comparison line is the rough cross-breed median in the FDA CVM database; values above suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 3.4 kg (7.5 lbs)
Top Reported Reactions
Lethargy (see also Central nervous system depression in Neurological) 4
Neutrophilia 3
Eosinophilia 3
Lack of efficacy - NOS 2
Limping 2
Lymphoedema 2
Pain NOS 2
Swelling NOS 2
Bone and joint disorder NOS 2
Leucocytosis NOS 2
Abnormal cytology 2
Enlarged lymph node (localised) 2
Blood and lymphatic system disorder NOS 2
Twitching 1
Ataxia 1
Most Referenced Drugs
Maropitant Citrate 5
Robenacoxib 4
Cefovecin 3
Prednisone 2
Cyclosporine 2
Eprinomectin + Esafoxolaner + Praziquantel 2
Sedative (Unknown) 2
Bupivacaine 2
Chlorambucil 1
Amitriptyline 1
Fluralaner Spot-On Solution 1
Capromorelin Tartrate 1
Ondansetron 1
Protamine Zinc Recombinant Human Insulin 1
Selamectin;Sarolaner 1
Outcome Breakdown
Ongoing
5 (38.5%)
Recovered/Normal
5 (38.5%)
Outcome Unknown
3 (23.1%)
Gender Distribution
Male 7 (53.8%)
Female 6 (46.2%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2012 | 1 | |
| 2015 | 1 | |
| 2019 | 2 | |
| 2023 | 4 | |
| 2024 | 5 | |
Singapura Pet Health Insights
Across the FDA Center for Veterinary Medicine adverse event database, Singapura accounts for 13 submitted reports and currently ranks #408 by report volume within the cat population. Of those reports, 0 involved a death outcome — a 0.0% case-fatality figure calculated directly from the underlying FDA records rather than from external mortality studies. The mean age at time of reporting is 7.1 years, with an average recorded body weight of 3.4 kg (7.5 lbs). These figures reflect the voluntary reporting pool only and should be read alongside breed popularity, veterinary access, and owner awareness — all of which shape how many events ever reach the FDA.
The most frequently reported clinical signs for Singapura are Lethargy (see also Central nervous system depression in Neurological) (4 reports), Neutrophilia (3 reports), Eosinophilia (3 reports), together capturing a substantial share of the top-reaction traffic seen in this breed's record. On the product side, Maropitant Citrate appears in 5 reports and is the single most-referenced drug, followed by Robenacoxib (4) and Cefovecin (3). Counts like these surface which therapeutic classes dominate the reporting stream — useful context when comparing reactions across breeds of the same cat species.
Outcome coding on the 13 reports with a recorded status is dominated by Ongoing (38.5% of coded outcomes). Annual submission volume ranges from 2,012 to 2,024 reports across the 5 years on file, indicating the reporting trend is shaped as much by awareness cycles as by underlying clinical events. Because FDA adverse event reports describe correlation rather than causation, these numbers are most useful as a signal of where to ask further questions with a veterinarian — not as a standalone risk score for any individual cat.
Understanding Singapura Adverse Event Data
Singapura has 13 adverse event reports on file. Lower report volumes may reflect a less common breed, lower reporting rates, or genuinely fewer adverse events.
A 0.0% death rate is below average in the FDA adverse event database, suggesting reported events tend toward less severe outcomes.
The most frequently referenced drug in adverse reports is Maropitant Citrate, appearing in 5 reports. This may indicate widespread use of the medication rather than a specific safety concern for Singapura.
Other Cat Breeds
Domestic Shorthair
61,410 reports · 720.0% death rate
Cat (unknown)
12,555 reports · 930.0% death rate
Domestic Longhair
9,078 reports · 690.0% death rate
Domestic (unspecified)
7,559 reports · 1340.0% death rate
Domestic Mediumhair
6,057 reports · 760.0% death rate
Cat (other)
4,619 reports · 970.0% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Singapura? ▼
There are 13 adverse event reports involving Singapura in the FDA database, with 0 reports involving death (0.0% death rate). Singapura ranks #408 by report volume.
What are the most common adverse reactions reported for Singapura? ▼
The most commonly reported adverse reactions for Singapura are Lethargy (see also Central nervous system depression in Neurological) (4 reports), Neutrophilia (3 reports), Eosinophilia (3 reports), Lack of efficacy - NOS (2 reports), Limping (2 reports).
What drugs are most frequently associated with Singapura adverse events? ▼
The drugs most frequently referenced in Singapura adverse event reports are Maropitant Citrate (5 reports), Robenacoxib (4 reports), Cefovecin (3 reports), Prednisone (2 reports), Cyclosporine (2 reports).
What is the average age of Singapura in adverse event reports? ▼
The average age of Singapura at the time of adverse event reports is 7.1 years, with an average weight of 3.4 kg (7.5 lbs).
Does a high number of adverse event reports mean Singapura is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Singapura safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Guides & Resources
Understanding Adverse Events
What FDA reports are and how they are collected
Breed-Specific Risks
Why some breeds appear in more adverse event reports
Pet Medication Safety
Evaluating medication risks using FDA data
Most Reported Medications
Drugs that appear most in adverse event reports
How FDA CVM Tracks Events
The reporting process and database limitations
Related Data Sources
Data Sources & Methodology
Adverse event data sourced from the FDA Center for Veterinary Medicine via the openFDA Animal & Veterinary Adverse Events API. Reports are voluntarily submitted by pet owners, veterinarians, and product manufacturers.
Singapura ranks #408 by total report volume. Death rate (0.0%) reflects the proportion of reports involving death and should not be interpreted as a breed-specific mortality rate. Reporting biases, breed popularity, and veterinary access all influence report counts.
Read our methodology — how this data is sourced, computed, and verified.
Related
Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial